Key facts
- This page summarizes Andrew J. Fromkin's Form 4 filing for Immunovant, Inc. (IMVT).
- 10 reported transactions and 4 derivative rows are listed below.
- Accepted by SEC: 29 May 2026, 16:04.
Andrew J. Fromkin - 28 May 2026 Form 4 Insider Report for Immunovant, Inc. (IMVT)
- Reporting relationship
- Director
- Issuer ticker
- IMVT
- Reported as of
- 28 May 2026
- Net transaction value
- -$7,438,111
- SEC form
- 4
- Accepted by SEC
- 29 May 2026, 16:04:59 UTC
- Prior SEC filing
- 09 Apr 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Tiago Girao, attorney-in-fact for Andrew J. Fromkin
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Andrew J. Fromkin filed Form 4 for Immunovant, Inc. (IMVT) on 29 May 2026.
Change
- Previous filing in this sequence was filed on 09 Apr 2026.
- Current net transaction value: -$7,438,111.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001341896
Primary reporting owner
Fromkin Andrew J.
- Relationship
- Director
- Address
- C/O IMMUNOVANT, INC., 1000 PARK FORTY PLAZA, SUITE 210, DURHAM
- Signature
- /s/ Tiago Girao, attorney-in-fact for Andrew J. Fromkin
- Signature date
- 29 May 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
IMVT
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +31,668
- Change %
- +32%
- Price
- $4.99*
- Shares after
- 131,400
- Date
- 28 May 2026
- Ownership
- Direct
IMVT
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +71,492
- Change %
- +54%
- Price
- $7.94*
- Shares after
- 202,892
- Date
- 28 May 2026
- Ownership
- Direct
IMVT
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +77,181
- Change %
- +38%
- Price
- $8.43*
- Shares after
- 280,073
- Date
- 28 May 2026
- Ownership
- Direct
IMVT
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +16,260
- Change %
- +5.8%
- Price
- $14.70*
- Shares after
- 296,333
- Date
- 28 May 2026
- Ownership
- Direct
IMVT
transaction
Common Stock
Sale
- Transaction value
- $374,805
- Shares
- -11,483
- Change %
- -3.9%
- Price
- $32.64
- Shares after
- 284,850
- Date
- 28 May 2026
- Ownership
- Direct
- Footnotes
- F1
IMVT
transaction
Common Stock
Sale
- Transaction value
- $7,063,306
- Shares
- -210,468
- Change %
- -74%
- Price
- $33.56
- Shares after
- 74,382
- Date
- 28 May 2026
- Ownership
- Direct
- Footnotes
- F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
IMVT
transaction
Derivative
Stock Option (right to buy)
Options Exercise
- Transaction value
- Shares
- -31,668
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 28 May 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 31,668
- Exercise price
- $4.99
- Footnotes
- F3
IMVT
transaction
Derivative
Stock Option (right to buy)
Options Exercise
- Transaction value
- Shares
- -71,492
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 28 May 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 71,492
- Exercise price
- $7.94
- Footnotes
- F3
IMVT
transaction
Derivative
Stock Option (right to buy)
Options Exercise
- Transaction value
- Shares
- -77,181
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 28 May 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 77,181
- Exercise price
- $8.43
- Footnotes
- F3
IMVT
transaction
Derivative
Stock Option (right to buy)
Options Exercise
- Transaction value
- Shares
- -16,260
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 28 May 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 16,260
- Exercise price
- $14.70
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.04 - $33.035 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
Footnote F2
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.04 - $33.85 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
Footnote F3
Reflects an award of stock options to purchase Common Shares that is fully vested.